Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo
J Stroke. 2016;18(2):169-178.   Published online 2016 May 10     DOI: https://doi.org/10.5853/jos.2016.00052
Citations to this article as recorded by Crossref logo
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
Yi‐Hsin Chan, Lai‐Chu See, Hui‐Tzu Tu, Yung‐Hsin Yeh, Shang‐Hung Chang, Lung‐Sheng Wu, Hsin‐Fu Lee, Chun‐Li Wang, Chang‐Fu Kuo, Chi‐Tai Kuo
Journal of the American Heart Association.2018;[Epub]     CrossRef
Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation
Yun Kyung Park, Mi Ji Lee, Jae Ha Kim, Jin Soo Lee, Rae Woong Park, Gyeong-Moon Kim, Chin-Sang Chung, Kwang Ho Lee, June Soo Kim, Soo-Youn Lee, Oh Young Bang
Journal of Stroke and Cerebrovascular Diseases.2017; 26(6): 1383.     CrossRef
Implications of CHA2DS2-VASc Score in Stroke Patients with Atrial Fibrillation: An Analysis of 938 Korean Patients
Jaechun Hwang, Jong-Won Chung, Mi Ji Lee, Gyeong-Moon Kim, Chin-Sang Chung, Kwang Ho Lee, Oh Young Bang
European Neurology.2017; 77(5-6): 307.     CrossRef